Category: Antisense & RNAi Technology
Antisense & RNAi Technology market research reports by Roots Analysis
-
Oligonucleotide Synthesis Market by Application Area (Research and Diagnostics, and Therapeutics), Type of Product Synthesized (Active Pharmaceutical Ingredients and Finished Dosage Forms), Type of Oligonucleotide Synthesized (Antisense, DNA, siRNA and Other Oligonucleotides), Scale of Operation (Clinical and Commercial), Therapeutic Area (Cardiovascular Disorders, Genetic Disorders, Liver Disorders, Rare Diseases, and Other Disorders), End-Users (Pharmaceutical / Biopharmaceutical Companies, Academic and Research Institutes, and Hospitals), Company Size (Small, Mid-sized, and Large and Very Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Oligonucleotide Synthesis Market by Application Area (Research and Diagnostics, and Therapeutics), Type of Product Synthesized (Active Pharmaceutical Ingredients and Finished Dosage Forms), Type of Oligonucleotide Synthesized (Antisense, DNA, siRNA and Other Oligonucleotides), Scale of Operation (Cl ... Read More
-
Oligonucleotide Synthesis, Modification and Purification Services Market (2nd Edition): Focus on Research, Diagnostic and Therapeutic Applications, 2021-2031
Oligonucleotide Synthesis, Modification and Purification Services Market (2nd Edition): Focus on Research, Diagnostic and Therapeutic Applications, 2021-2031 INTRODUCTION Post the marketing of Vitravene®, the first antisense oligonucleotide-based therapy to receive approval (in 1998), various stakeh ... Read More
-
DNA Synthesis Technologies and Services Market, 2022-2035
DNA Synthesis Technologies and Services Market, 2022-2035 DNA or RNA molecules find a variety of applications in the biopharmaceutical industry for genetic testing, medical research, therapeutic development, forensic investigation, and other analytical processes. It is worth highlighting that severa ... Read More
-
Investor Series: Opportunities in RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers)
Investor Series: Opportunities in RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers) INTRODUCTION to RNA Therapeutics RNA therapeutics are known to target specific genetic sequences of individual patients, in order to provide more effective treatment option ... Read More
-
RNAi Therapeutics and Technology Market (3rd Edition): Focus on siRNA, miRNA, shRNA, sshRNA and DNA, 2022-2035
RNAi Therapeutics and Technology Market (3rd Edition): Focus on siRNA, miRNA, shRNA, sshRNA and DNA, 2022-2035 INTRODUCTION RNAi therapeutics have garnered significant attention post the 2006 Nobel Prize that was awarded to Andrew Fire and Craig Mello for the discovery of RNA interference (RNAi). Su ... Read More
Research Assistance
